On 6th August, a group of PhD published in The Lancet that:
A new syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has emerged as a rare side-effect of vaccination against COVID-19.
The Lancet, an international weekly medical journal, reports that a new syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has emerged after vaccination for COVID. According to reports, cerebral venous thrombosis (CVT) is the most common manifestation of VITT and certain CVT cases have been determined as being vaccine-induced.
Data collected earlier this year from 99 patients among 43 U.K. hospitals show that after four patients were excluded because tests showed no definitive evidence of cerebral venous thrombosis, 70 of the remaining 95 patients had VITT, and 25 did not. According to the study, death occurred more frequently in patients with VITT-associated CVT as compared with the non-VITT control group
After the introduction of the AstraZeneca vaccine, five cases of severe VITT were reported in Norway, with four of those cases being CVT, according to reports. A similar condition was noted with the Johnson & Johnson vaccine and case reports also associate two mRNA vaccines — Moderna and Pfizer —with thrombocytopenia, only with slightly different symptoms.
Globally, more than 4·1 million people have died from COVID-19.
In response to this public health emergency, several vaccines against COVID-19 have been developed, with more than 3·7 billion doses administered worldwide. After the introduction of the adenovirus vector vaccine ChAdOx1 (Oxford–AstraZeneca), five cases of severe venous thrombosis with thrombocytopenia were reported in Norway, each starting 7–10 days after administration of the first vaccine dose. Four of these cases had cerebral venous sinus thrombosis.
This syndrome has since been termed vaccine-induced immune thrombotic thrombocytopenia (VITT).
Disclaimer: The entire contents of this page are based upon the opinions of Dr. Mercola and the report published by a group of PhD in The Lancet unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Mercola and his community. Dr. Mercola encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.